Milestone Pharmaceuticals Inc. (MIST): Total Liabilities
$71.79M
As of 2025-12-31
$163.41M
As of 2026-06-30
+106.7%
3-year compound annual growth
+60.0%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $71.79M | +15.1% | 2026-03-20, Balance as of period end |
| 2024-12-31 | $62.35M | +6.7% | 2026-03-20, Balance as of period end |
| 2023-12-31 | $58.45M | +618.6% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $8.13M | +12.2% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $7.25M | +5.7% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $6.86M | -19.5% | 2022-03-24, Balance as of period end |
| 2019-12-31 | $8.51M | +87.8% | 2021-03-29, Balance as of period end |
| 2018-12-31 | $4.53M | n/a | 2020-10-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $71.79M | +15.1% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $62.07M | -5.7% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $15.74M | +48.8% |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $12.16M | -9.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $11.85M | -22.1% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $10.55M | +95.6% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $70.10M | +362.3% |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $43.95M | +271.6% |
Compare MIST, KRRO, RFL, RZLT side by side · Screen every company in Pharmaceutical Preparations ↗